A. Schellekens

461 total citations
7 papers, 354 citations indexed

About

A. Schellekens is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Oncology. According to data from OpenAlex, A. Schellekens has authored 7 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 7 papers in Psychiatry and Mental health and 4 papers in Oncology. Recurrent topics in A. Schellekens's work include Pharmacological Effects and Toxicity Studies (7 papers), Epilepsy research and treatment (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). A. Schellekens is often cited by papers focused on Pharmacological Effects and Toxicity Studies (7 papers), Epilepsy research and treatment (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). A. Schellekens collaborates with scholars based in Netherlands. A. Schellekens's co-authors include J.A.R.J. Hulsman, Albert P. Aldenkamp, Marian Majoie, Danielle A.J.E. Lambrechts, H. Bootsma, Marc de Krom, L. Diepman, L. Leenen, Lukas J. A. G. Ricker and Johan Arends and has published in prestigious journals such as Epilepsia, European Journal of Clinical Pharmacology and Epilepsy & Behavior.

In The Last Decade

A. Schellekens

7 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Schellekens Netherlands 7 300 246 93 41 30 7 354
Y. Sturm Switzerland 9 422 1.4× 418 1.7× 114 1.2× 26 0.6× 17 0.6× 11 513
H. G. Wieser Switzerland 4 343 1.1× 271 1.1× 121 1.3× 72 1.8× 24 0.8× 10 417
Blaise Bourgeois United States 9 268 0.9× 194 0.8× 99 1.1× 34 0.8× 20 0.7× 15 312
Pascal Edrich United States 9 377 1.3× 343 1.4× 160 1.7× 38 0.9× 11 0.4× 13 449
Steffi Koch‐Stoecker Germany 10 305 1.0× 205 0.8× 85 0.9× 45 1.1× 14 0.5× 13 339
George Mawer United Kingdom 9 366 1.2× 462 1.9× 38 0.4× 31 0.8× 31 1.0× 10 579
J.C. Doelman Netherlands 7 255 0.8× 214 0.9× 81 0.9× 36 0.9× 67 2.2× 8 358
Simon Borghs United Kingdom 14 592 2.0× 529 2.2× 270 2.9× 39 1.0× 27 0.9× 39 660
Thomas E. Beniak United States 7 259 0.9× 182 0.7× 85 0.9× 78 1.9× 10 0.3× 9 316
Charlotte Lawthom United Kingdom 9 170 0.6× 119 0.5× 54 0.6× 19 0.5× 25 0.8× 28 258

Countries citing papers authored by A. Schellekens

Since Specialization
Citations

This map shows the geographic impact of A. Schellekens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Schellekens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Schellekens more than expected).

Fields of papers citing papers by A. Schellekens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Schellekens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Schellekens. The network helps show where A. Schellekens may publish in the future.

Co-authorship network of co-authors of A. Schellekens

This figure shows the co-authorship network connecting the top 25 collaborators of A. Schellekens. A scholar is included among the top collaborators of A. Schellekens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Schellekens. A. Schellekens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bootsma, H., Lukas J. A. G. Ricker, Yechiel A. Hekster, et al.. (2008). The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure. 18(5). 327–331. 99 indexed citations
2.
Bootsma, H., Aurin M. Vos, J.A.R.J. Hulsman, et al.. (2008). Lamotrigine in clinical practice: Long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy & Behavior. 12(2). 262–268. 20 indexed citations
3.
Bootsma, H., Lukas J. A. G. Ricker, L. Diepman, et al.. (2007). Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison. Seizure. 17(1). 19–26. 52 indexed citations
4.
Aldenkamp, Albert P., L. Diepman, J.A.R.J. Hulsman, et al.. (2006). The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice. Epilepsia. 47(s2). 24–27. 34 indexed citations
5.
Bootsma, H., Frank P. A. Coolen, Albert P. Aldenkamp, et al.. (2004). Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy & Behavior. 5(3). 380–387. 57 indexed citations
6.
Aldenkamp, Albert P., Johan Arends, H. Bootsma, et al.. (2002). Randomized Double‐blind Parallel‐group Study Comparing Cognitive Effects of a Low‐dose Lamotrigine with Valproate and Placebo in Healthy Volunteers. Epilepsia. 43(1). 19–26. 72 indexed citations
7.
Aldenkamp, Albert P., J.A.R.J. Hulsman, Marian Majoie, et al.. (1998). Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates. European Journal of Clinical Pharmacology. 54(2). 185–192. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026